Brighthouse Financial BHF 深 沪
等待开盘 10-25 09:30:00 美东时间
46.64
-0.370
-0.79%
华盛通- 最 高47.29
- 今 开47.24
- 成交量 51.15万股
- 最 低 46.28
- 昨 收 47.01
- 总市值 26.78亿
- 52周最高 64.12
- 市盈率 静 10.05
- 换手率 0.89%
- 52周最低 42.07
- 委 比 60.45%
- 总股本 5740.90万
- 历史最高 67.55
- 量 比 0.49
- 振 幅 2.15%
- 历史最低 12.05
- 每 手 1
- 风险率 5.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多'Brighthouse Financial Is In Talks With Sixth Street For Sale At Roughly $55 Per Share; Brighthouse Reached Impasse With Aquarian Holdings In Late-September Over Funding Structure; Brighthouse Deal With Sixth Street Would Value Insurer At Roughly $3.1B' - Reuters Exclusive
Sixth Street is in talks to buy Brighthouse for roughly $55/shareBrighthouse held negotiations with Aquarian, but efforts fizzledSixth Street deal would value Brighthouse at around $3.1 billion, end long-running saga
10-17 00:58
快讯 | 独家：据消息人士透露，Brighthouse Financial正与Sixth Street就以每股约55美元的价格出售进行谈判
Exclusive-Brighthouse Financial Is in Talks With Sixth Street for Sale at Rough...
10-17 00:57
每日数字货币动态汇总（2025-10-16）
小程序：每日数字货币动态汇总 1. 英国计划向68亿美元比特币诈骗案的中国受害者赔偿 据Decrypt报道，尽管英国政府曾有意保留大部分资金，但英国检察官正计划...
10-16 11:00
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Seven & i Holdings GAAP EPS of ¥47.83, revenue of ¥5.62T
Seven & i Holdings press release (OTCPK:SVNDY): 1H GAAP EPS of ¥47.83. Revenue of ¥5.62B (-7.0% Y/Y). More on Seven & i Holdings Seven & i Is Priced For No Growth Seven & i CEO: 7-Eleven U.S. IPO woul...
10-10 02:30
美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
10-09 10:51
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
Morgan Stanley Maintains Underweight on Brighthouse Finl, Raises Price Target to $46
Morgan Stanley analyst Nigel Dally maintains Brighthouse Finl (NASDAQ:BHF) with a Underweight and raises the price target from $42 to $46.
10-07 22:33
Huntington Bancshares, Veritex get all regulatory approvals for merger
Huntington Bancshares (NASDAQ:HBAN) and Veritex Holdings (NASDAQ:VBTX) said the Federal Reserve Board of Governors and the Office of the Comptroller of the Currency have approved the proposed merger o...
10-04 03:47
California Resources announces redemption of 7.125% senior notes due 2026
California Resources (CRC) announced on Tuesday that it has issued a notice of redemption with respect to its 7.125% Senior Notes due 2026. On October 10, 2025, the company will redeem all the 2026 no...
10-01 05:18
